A Versatile Approach for Siteâ  Specific Lysine Acylation in Proteins by Wang, Zhipeng A. et al.
Supporting Information
AVersatile Approach for Site-Specific Lysine Acylation in Proteins
Zhipeng A. Wang+, Yadagiri Kurra+, Xin Wang+, Yu Zeng, Yan-Jiun Lee, Vangmayee Sharma,
Hening Lin, Susie Y. Dai,* and Wenshe R. Liu*
anie_201611415_sm_miscellaneous_information.pdf
2		
Contents 
 
1. Chemical synthesis of AznL, dPPMT-Ac, dPPMT-Su, and dPPMT-NB-Su 
•••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• S3 
2. The identification of AznLRS ••••••••••••••••••••••••••••••••••••••••••••••••••••••••• S13 
3. The expression of sfGFP-D134AznL ••••••••••••••••••••••••••••••••••••••••••••••••• S14 
4. The expression of Ub-K48AznL, WT-Ub, and Ub-K48ac 
•••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• S17 
5. The expression of histone H3-K4AznL, WT-H3, and H4-His6-SUMO •••••••••• S19 
6. General process of time-dependent traceless-Staudinger ligation of Ub-K48AznL and 
H3K4AznL •••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• S20 
7. MS analysis of sfGFP-D134AznL, Ub-K48ac, and Ub-K48su ••••••••••••••••••• S21 
8. Tandem MS/MS analysis of Ub-K48ac, Ub-K48su, and H3-K4su •••••••••••••• S22 
9. The preparation of H3-K4su ••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• S22 
10. Refolding of H3K4su-H4 tetramer •••••••••••••••••••••••••••••••••••••••••••••••••• S23 
11. Sirtuin enzyme expression and deacylation assay ••••••••••••••••••••••••••••••••• S23 
 
Appendix •••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• S25 
 
 
 
 
 
 
 
 
 
 
  
3		
1. Chemical synthesis of AznL, dPPMT-Ac, dPPMT-Su, and dPPMT-NB-Su 
1.1 Synthesis of AznL 
SI scheme 1: 
 
Synthesis of imidazole-1-sulfonyl azide (1): To the solution of sodium azide (1.31 g, 20.2 
mmol) in anhydrous acetonitrile (30 mL) was added sulfuryl chloride solution (97% solution, 1.7 
mL, 20.4 mmol) dropwise in an ice bath. The mixture was then stirred at r.t. for 8 h. Imidazole 
(2.78 g, 40.9 mmol) was added into the mixture in an ice bath and the afforded solution was 
stirred at r.t. for another 8 h. The mixture of white slurry was partitioned with EtOAc/H2O 
solution and the organic layer was collected and washed with H2O, saturated aqueous NaHCO3, 
and brine, dried over anhydrous sodium sulfate, and filtered. Hydrogen chloride solution (1 M in 
EtOAc, 12 mL, 12 mmol) was added into the filtrate in an ice bath. The afforded white 
suspension was collected by filtration. The filter cake was washed with cold ethanol and EtOAc 
to afford imidazole-1-fulfonyl azide hydrochloride (1) as the desired product (2.2 g, 52%) in 
white solid. 1H NMR (D2O, 300 MHz) δ 8.88 (br, 1H), 7.87 (br, 1H), 7.44 (br, 1H). MS (Free 
base + H+): Calc. 174.0, Obs. 174.0362.  
 
SI scheme 2: 
 
Synthesis of compound (3a): The synthetic procedure of AznL is a modified version from 
reference1, which contains four steps. 9.51 g of Boc-Lys(Cbz)-OH (2) (25 mmol, Sigma-Aldrich) 
was dissolved in dry DMF, followed by the addition of K2CO3 (7.26 g, 52.5 mmol). 3.44 mL of 
MeI (55 mmol) was gradually added, and was let to stir overnight at 80 oC. Then the reaction 																																																								1	 Link	A.,	Vink	M.	K.	S.,	Tirrell	D.	A.,	Nat.	Protocols	2007,	2,	1879-1883	
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mixture was quenched by the addition of 50 mL H2O, and extracted by EtOAc 30 mL for 3 times. 
The EtOAc layers were combined, washed with brine, and dried by anhydrous Na2SO4. The 
crude product was then purified by the silica gel flash column chromatography (eluted at 10% 
EtOAc/hexane) to give an oil product (3a) (9.6 g, 97%).  
 
Synthesis of compound (3b): The solution of Boc-Lys(Cbz)-OMe (3a) (3.9 g, 10 mmol) in 
methanol (100 mL) was added palladium on activated carbon (Pd 10%, 0.6 g, 0.6 mmol). The 
mixture was stirred at r.t. with hydrogen bubbled through where the reaction progress was 
monitored by the TLC analysis. The reaction was terminated as the starting protected amino acid 
on TLC disappeared. Then the reaction mixture was filtered through a celite cake packed on a 
Buchner funnel and the flowed-through solution was concentrated under reduced pressure to 
afford colorless oil that was characterized as the desired product (3b). The product was directly 
used in the next step without further purification. 
 
Synthesis of compound (4): Boc-Lys-OMe (3b) (0.81 g, 3.1 mmol) from the previous step was 
dissolved in methanol (20 mL). CuSO4 5H2O (6.8 mg, 0.45 mmol) and K2CO3 (888 mg, 6.4 
mmol) were added into the solution followed by the addition of imidazole-1-sulfonyl azide 
hydrochloride (1) (650 mg, 3.1 mmol) into the mixture in an ice bath. The resulting mixture was 
stirred at r.t. for 8 h. After addition of EtOAc (10 mL), the diluted mixture was then washed with 
water, saturated aqueous NaHCO3, brine, dried over anhydrous sodium sulfate, filtered, and 
concentrated under reduced pressure. The crude product was further purified by the silica gel 
flash column chromatography (eluted at 5% EtOAc/hexane) to give a clear oil as the desired 
product (4) (0.7 g, 79%). 1HNMR (CDCl3, 300 MHz). δ 5.09 (d, 1H, J = 1.6 Hz), 4.33 (dd, 1H, J 
= 1.6, 1.8 Hz), 3.77 (s, 3H), 3.24 (t, 2H, J = 1.2 Hz), 1.99-1.78 (m, 2H), 1.78-1.58 (m, 2H), 
1.58-1.32 (m, 12H).  
 
Synthesis of AznL: The solution of ester from the previous step (4) (0.7 g, 2.4 mmol) in a 1:1 
mixture of methanol and THF (24 mL) was added LiOH aqueous solution (0.5 M, 24 mL) and 
stirred at r.t. The reaction progress was monitored by the TLC analysis. After 5 h, the spot 
representing the starting ester on TLC plate disappeared. The reaction mixture was then diluted 
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with EtOAc/H2O. After partition, the organic layer was discarded and the aqueous layer was 
acidified by the addition of 3M HCl until pH was adjusted to 3-4. The mixture was than 
extracted with EtOAc twice. The organic layers was combined, washed with brine, dried over 
anhydrous Na2SO4, and concentrated to afford clear sticky oil as the desired product which was 
subjected directly to next step without chromatography purification.  
 
The afforded acid from the previous step (0.8 g, 2.9 mmol) in dioxane (5 mL) was added into a 
HCl solution (4 M in dioxane, 10 mL). The mixture was stirred at r.t. The reaction progress was 
monitored by TLC. After reaction for 3 h, the HCl solution were removed under reduced 
pressure. The afforded oil was dissolved in minimal amount of water, neutralized with aqueous 
sodium hydroxide and subjected to the ion exchange chromatography (Dowex 50WX4) to afford 
a pale while solid as the desired product (AznL) (150 mg, 36% for two steps). 1H NMR (D2O, 
300 MHz). δ 4.17 (t, 1H, J = 1.4 Hz), 3.35 (t, 2H, J = 1.2 Hz), 2.10-1.79 (m, 2H), 1.78-1.30 (m, 
4H). MS (Aznl+H+): Calc. 173.1, Obs. 173.1040. 
 
1.2 Synthesis of dPPMT-Ac 
SI scheme 3: 
 
Synthesis of Compound (5): Chloromethylphosphonic dichloride (2 g, 12 mmol) was dissolved 
in freshly distilled THF (30 mL). A solution of phenylmagnesium bromide (1.0 M) in THF (24 
mL, 24 mmol) was added dropwise over 30 min. The resulting mixture was stirred at reflux for 
24 h. The reaction was then quenched by the addition of water (20 mL), and solvent was 
removed under reduced pressure. The residue was taken up in CH2Cl2 and washed once with 
water (50 mL) and once with brine (50 mL). The organic layer was dried over anhydrous MgSO4 
and filtered, and solvent was removed under reduced pressure. The residue was purified by flash 
chromatography (silica gel, 3% MeOH in CH2Cl2). Phosphine oxide 5 was isolated as a white 
solid in 63% yield. 1HNMR (CDCl3, 300 MHz) δ 7.84-7.79 (m, 4H), 7.60-7.59 (m, 2H), 
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7.55-7.49 (m, 4H), 4.05 (d, 2H, J= 4.2 Hz). 31P NMR (CDCl3, 200 MHz) δ 28.3.  
 
Synthesis of Compound AcSCH2P(O)(C6H4)2 (6). Phosphine oxide 5 (1.2 g, 4.8 mmol) was 
dissolved in DMF (20 mL). Potassium thioacetate (0.829 g, 5.76 mmol) was then added, and the 
reaction mixture was stirred under Ar(g) for 18 h. The solvent was then removed under reduced 
pressure. The resulting oil was purified by chromatography (3% v/v MeOH in CH2Cl2). 
Phosphine oxide 6 was isolated as a clear, colorless oil in 70 % yield. 1HNMR (CDCl3, 300 MHz) 
δ 7.78-7.74 (m, 4H), 7.54-7.53(m, 2H), 7.49-7.45 (m, 4H), 3.77 (d, 2H, J = 4.1 Hz), 2.25 (s, 3H). 
13CNMR (CDCl3, 75MHz) δ 193 (d), 132.3, 132.3, 131.5, 131.1, 131.0, 130.7, 128.7, 128.6, 30.0, 
27.6 (d). 31P NMR (CDCl3, 200 MHz) δ 28.9.  
 
Synthesis of Compound AcSCH2P(C6H4)2 (7). Phosphine oxide 6 (1.06 g, 4 mmol) was 
dissolved in anhydrous chloroform (10 mL). Trichlorosilane (8 mL, 90 mmol) was added, and 
the resulting solution was stirred under Ar(g) for 72 h. The solvent was then removed under 
reduced pressure. (CAUTION: Excess trichlorosilane in the removed solvent was quenched by 
the slow addition of saturated sodium bicarbonate in a well-ventilated hood.) The residue was 
purified by flash chromatography (silica gel, 3% v/v MeOH in CH2Cl2). Phosphine 7 was 
isolated as a white solid in 65%% yield. Spectral Data. 1HNMR (CDCl3, 300 MHz) δ 7.45-7.41 
(m, 3H), 7.40-7.33(m, 7H), 3.52 (t, 2H, J = 1.8, 3.3 Hz), 2.29 (s, 3H). 13CNMR (CDCl3, 75MHz) 
δ 193, 136.8, 136.6, 132.8, 132.6, 131.0, 129.1, 128.6, 128.5, 30.2, 25.9 (d). 31P NMR (CDCl3, 
200 MHz) δ -15.33.  
 
1.3 Synthesis of dPPMT-Su 
SI scheme 4: 
 
To a mixture of succinic anhydride (3 g, 0.3 mol), N-hydroxysuccinimide (1 g, 0.009 mol), and 
DMAP (0.35 g, 0.003 mol) in toluene (15 mL) were added tert-butyl alcohol (3.5 mL, 0.037 mol) 
OO O OO N
OH OH
HO O
O
O
+ Et3N
toluene, reflux, 12 h
8
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and Et3N (0.009 mol, 1.25 mL). The suspension was refluxed for 24 h. The solution was cooled 
and diluted with EtOAc (15 mL). The reaction mixture was washed with 10% citric acid and 
brine, dried over Na2SO4, and concentrated to give a brown oil. The oil was recrystallized with 
ether and petroleum ether at -20 °C to give the desired product 8 as a white crystal (4.0 g, 
78%).1H NMR (CDCl3, 300 MHz): δ 2.62 (t, 2H, J = 3.3 Hz), 2.54 (t, 2H, J =1.2 Hz), 1.44 (s, 
9H), 13CNMR (CDCl3, 75MHz): 178.5, 171.4, 81.0, 30.0, 29.1, 28.0.  
 
SI scheme 5: 
 
 
Synthesis of phosphine oxide (9): A 250 mL round bottom flask equipped with an addition 
funnel was evacuated and Ar filled for 3 times, charged with 50 mL 1 M PhMgBr/THF (71.7 mL, 
71.7 mmol, 3.3 eq.), and the solution cooled to 0 oC under Ar. A solution of 3 g diethylphosphite 
(21.7 mmol, 1.0 eq) in 10 mL THF was then added dropwise over 15 min. The mixture was let 
stand for 15 min at 0 oC, then the bath was removed, and the mixture was stirred for two hours at 
ambient temperature and then cooled again to 0 oC. 75 mL 0.1 N HCl was added dropwise over 
20 min, then 75 mL MTBE was added, and the mixture was filtered through a celite pad 
followed by washing the pad with CH2Cl2. The filtrate phases were separated, and the organic 
phase combined with the first organic phase, dried by MgSO4, and the solvents removed in 
vacuo. The residue was purified by flash column chromatography to give 9 (3.0 g, 70%) 1H 
NMR (500 MHz, CDCl3) δ: 8.87 (s. 1H), 7.73-7.50 (m, 4H), 7.49-7.45 (m, 6H). 13C NMR (75 
MHz, CDCl3) δ: 132.5, 132.5, 130.6, 130.5, 128.9, 128.7. 31PNMR (500MHz, CDCl3): δ: 21.4.  
 
Phosphine-Borane Complex (10). A solution of phosphine oxide 9 (2.00 g, 9.90 mmol) in 
anhydrous CH2Cl2 (30 mL) was added dropwise slowly to a solution of DIBAL (1 M in CH2Cl2, 
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39.6 mL, 39.6 mmol) under Ar(g) in a flame-dried three-neck round-bottom flask. The resulting 
solution was stirred for 20 min, and then cooled to 0 °C with an ice bath. The solution was then 
diluted with CH2Cl2 (30 mL), and a sparge needle of Ar(g) was allowed to blow through the 
solution for 5 min. A solution of 2 N NaOH (20 mL) was added dropwise slowly to the reaction 
mixture (Caution! Gas evolution!) followed by a saturated solution of Rochelle’s salt (20 mL) to 
dissipate the emulsion that forms. The resulting biphasic solution was transferred to a separatory 
funnel, and the organic layer was separated, dried over anhydrous MgSO4, filtered, and 
concentrated under reduced pressure. (1.8 g 100%). Borane-dimethylsulfide (3 M solution in 
THF, 6.45 mL, 19.35 mmol) was added to a round-bottom flask with freshly distilled THF (20 
mL). To this solution, The crude diphenylphosphine (1.8 g, 9.67  mmol) was added in one 
portion. The solution was stirred under nitrogen for 2 h, and was quenched slowly with ice (~10 
g). The resulting solution was diluted with brine (20 mL), and extracted with EtOAc (3 x 20 mL). 
The combined organic layers were washed with brine (2 x 10 mL), dried over sodium sulfate, 
filtered, and the solvent was removed under reduced pressure and the crude oil was purified by 
flash chromatography to yield 10 (1.1 g, 60% yield). 1H NMR (500 MHz, CDCl3) δ: 7.73-7.66 
(m. 4H), 7.54-7.45 (m, 6H). 31PNMR (500MHz, CDCl3): δ: 22.1. 
 
Diphenylphosphino(borane)methane alcohol (11): 10 (1.0 g, 5.0 mmol) was dissolved in a 
mixture of aqueous formaldehyde (37% w/w, 5 mL) and THF (10 mL). To this solution, KOH 
(700 mg, 10.0 mmol) was added. The solution was stirred for 2 h, and the volatile solvent was 
removed under reduced pressure. The resulting aqueous solution was extracted with EtOAc (3 x 
10 mL), washed with brine (1 x mL), dried over sodium sulfate, filtered, and the solvent was 
removed under reduced pressure and the crude product was purified by flash chromatography to 
yield 11 as a colorless liquid (0.861 g, 70%). 1H NMR (CDCl3, 300 MHz): δ 7.76-7.72 (m, 4H), 
7.55-7.53(m, 2H), 7.50-7.47 (m, 4H), 4.45 (s, 3H), 2.05 (br, 1H), 1.46-0.52 (m, 3H); 13C NMR 
(CDCl3, 75 MHz) δ 132.8, 132.7, 131.7, 131.7, 129.0, 128.9, 126.9, 126.4, 60.5, 60.2. 31P NMR 
(CDCl3, 300 MHz) δ 25.7.  
 
Diphenylphosphino(borane)methyl methanesulfonate (12): 11 (1.1 g, 5.0 mmol) was 
dissolved in freshly distilled methylene chloride (10 mL), followed by addition of triethylamine 
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(1.4 mL, 10.1 mmol). The solution was cooled to 0 °C with ice-water bath. To this solution, 
methanesulfonyl chloride (580.0 µL, 7.4 mmol) was added dropwise. The solution was stirred 
under nitrogen for 15 h. The solvent was removed under reduced pressure. The crude product 
was purified by flash chromatography (3:1 C6H14:EtOAc) to yield 12 as a white solid (1.0 g, 3.9 
mmol, 70%). 1H NMR (CDCl3, 300 MHz) δ 7.76-7.72 (m, 4H), 7.59-7.57 (m, 2H), 7.53-7.49 (m, 
4H), 4.91 (d, 2H, J=1.2 Hz,), 2.89 (s, 3H). 31P NMR (CDCl3, 300 MHz) δ 18.2.  
 
Diphenylphosphino(borane)methanethiol acetate (13): Potassium thioacetate (0.737 g, 5.12 
mmol) was added to a solution of 12 (0.8 g, 2.58 mmol) in anhydrous DMF (15 mL) under Ar(g). 
The resulting solution was stirred overnight at room temperature, after which the solvent was 
removed under reduced pressure. The residue was dissolved in EtOAc (20 mL), and the resulting 
solution was washed with water and brine. The combined organic extracts were dried over 
anhydrous MgSO4, filtered, and the solvent was removed under reduced pressure. The crude 
product was purified by flash chromatography (4:1 hexanes:ethyl acetate) to yield 13 as a white 
solid (0.487 g, 65%). 1H NMR (CDCl3, 300 MHz) δ 7.71-7.67 (m, 4H), 7.51-7.49 (m, 2H), 
7.46-7.43 (m, 4H), 3.72 (d, 2H, J =4.5 Hz), 2.24 (s, 3H). 13C NMR (CDCl3, 75 MHz) δ 193.2, 
132.4, 132.4, 131.8, 131.7, 128.9. 128.8, 127.8, 127.3, 30.0, 23.9 (d).31P NMR (CDCl3, 300 MHz) 
δ 19.0 (d).  
 
Diphenylphosphino(borane))methanethiol-2-Nitrobenzylsuccinate ester (15) 
Thioacetate 13 (0.4 g, 1.38 mmol) was dissolved in freshly distilled methanol (5 mL), followed 
by addition of sodium hydroxide (66 mg, 1,66 mmol). After stirring under nitrogen for 10 min, 
the solution was neutralized by 1 N hydrochloric acid, and was extracted with ethyl acetate (2 x 
30 mL). The combined organic layers were washed by brine (1 x 10 mL), dried over sodium 
sulfate, filtered, and concentrated under reduced pressure. The crude thiol (14) was dissolved in 
freshly distilled methylene chloride (10 mL), followed by addition of o-Nitrobenzylsuccinate 
ester (NBS) (8) (0.408 g, 1.58 mmol), 1,3-dicyclohexylcarbodiimide (0.4 g, 0.97 mmol), and cat. 
N,N’-dimethyl-4-aminopyridine. The solution was stirred under nitrogen for 4 h, and the solution 
was filtered through a pad of celite. The solvent was removed under reduced pressure. The crude 
product was purified by flash chromatography (3:1 hexanes:ethyl acetate) to yield the thioester 
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15 as a colorless oil (0.432g, 65%). 1H NMR (CDCl3, 300MHz) δ 8.10 (t, 1H, J = 1.2 Hz), 
7.85-7.83 (m, 1H), 7.82-7.80 (m, 4 H), 7.69-7.43 (m, 8H), 5.61 (s, 2H), 3.73 (d, 2H, J = 1.2 Hz), 
2.85 (t, 2H, J = 4.2 Hz), 2.67 (t, 2H, J = 4.2 Hz). 13C NMR (CDCl3, 75 MHz) δ 195 (d), 170, 
147.4, 133.9, 132.4, 132.4, 132.0, 131.8, 131.4, 131.3, 129.0, 128.9, 128.9, 128.8, 128.7, 128.6, 
127.6, 127.2, 125.0, 63.3, 37.9, 29.0, 23.6 (d). 31P NMR (CDCl3, 300 MHz) δ 40.4; 
 
Diphenylphosphino(borane))methanethiol-mono-t-butyl succinate ester (15) 
13 (0.4 g, 1.38 mmol) was dissolved in freshly distilled methanol (5 mL), followed by addition 
of NaOH (66 mg, 1,66 mmol). After stirring under nitrogen for 10 min, the solution was 
neutralized by 1 N HCl, and was extracted with EtOAc (2 x 30 mL). The combined organic 
layers were washed by brine (1 x 10 mL), dried over sodium sulfate, filtered, and concentrated 
under reduced pressure to obtain 14. The crude thiol of 14 was dissolved in freshly distilled 
CH2Cl2 (10 mL), followed by the addition of 8 (0.352 g, 2.0 mmol), 
1,3-dicyclohexylcarbodiimide (0.5 g, 2,42 mmol), and cat. N,N’-dimethyl-4-aminopyridine. The 
solution was stirred under nitrogen for 4 h, and the solution was filtered through a pad of celite. 
The solvent was removed under reduced pressure. The crude product was purified by flash 
chromatography (3:1 C6H14:EtOAc) to yield the thioester 15 as a colorless oil (0.33 g, 60%). 1H 
NMR (CDCl3, 300 MHz) δ 7.72-7.68 (m, 4H), 7.53-7.45 (m, 6H), 3.75 (d, 2H, J = 3.9 Hz), 2.75 
(t, 2H, J  = 3.9 Hz), 2.48 (t, 2H, J = 3.3 Hz), 1.43 (s, 9H). 13C NMR (CDCl3, 75 MHz) δ 195 (d), 
170.6, 132.5, 132.4, 131.8, 131.7, 128.9, 128.8, 127.8, 127.3, 38.4, 30.3, 28.0, 23.5 (d).  
31PNMR (CDCl3, 75 MHz) δ 41.5.  
 
Diphenylphosphinomethanethiol-mono-t-butyl succinate ester (16) 
Phosphine-borane 15 (0.25 g, 0.621 mmol) and 1,4-diazabicyclo[2.2.2]octane (DABCO) (0.139 
g mg, 1.24 mmol) was dissolved in freshly distilled toluene (2 mL). The solution was submerged 
in an oil-bath pre-heated to 60 °C. The solution was stirred under argon for 1 h. After cooling to 
room temperature, the solvent was removed under reduced pressure. The crude product was 
purified by flash chromatography (4:1 C6H14:EtOAc) under nitrogen to yield 16 as a colorless oil 
(0.168 g, 70%). 1H NMR (CDCl3) δ 7.46-7.43 (m, 4H), 7.37-7.36 (m, 6H), 3.55 (d, 2H, J = 2.1 
Hz), 2.80 (t, 2H, J  = 4.2 Hz), 2.55 (t, 2H, J = 4.5 Hz), 1.45 (s, 9H).  13C NMR (CDCl3, 75 
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MHz) δ 196 (d), 170.9, 136.8, 136.7, 132.8, 132.6, 129.1, 128.6, 128.5, 80.9, 38.5, 30.5, 28.0, 
25.6, 25.4 (d).  31P NMR (CDCl3, 300 MHz) δ - 15.3. 
 
Diphenylphosphinomethanethiol-succinic acid (17) 
 To a solution of ester 16 (0.15 g, 0.45  mmol) in CH2Cl2 (3 mL) was added TFA (3 mL). After 
being stirred at r.t. for 1 h, the reaction mixture was concentrated in vacuum to give a colorless 
oil 17 (0.098 g, 73%). 1H NMR (CD3OH, 300 MHz) δ 7.44-7.42 (m, 4H), 7.41-7.36 (m, 6H), 
3.56 (d, 2H, J = 2.4 Hz), 2.82 (t, 2H, J  = 4.2 Hz), 2.58 (t, 2H, J = 4.2 Hz). 13C NMR (CDCl3, 75 
MHz) δ 196.9 (d), 174.0, 136.8, 132.5, 132.3, 128.8, 128.3, 128.2, 37.8, 28.4, 24.8 (d). 31P NMR 
(CDCl3, 300 MHz) δ - 14.9. 
 
1.4 Synthesis of dPPMT-NB-Su 
SI scheme 6: 
 
O-nitrobenzyl alcohol (4.0 g, 26.12 mmol), succinic anhydride (5.23 g, 52.24 mmol), and DMAP 
(1.60 g, 13.06 mmol) were dissolved completely in dried CHCl3 (86 mL) and refluxed under a 
nitrogen atmosphere for 24 h. After removing partially CHCl3 under reduced pressure, the 
mixture was washed three times with 10% HCl and then extracted with saturated NaHCO3 
solution. The basic aqueous phase was washed with ether and acidified to pH 5.0 with 10% HCl. 
The white solid precipitate was collected and dried in vacuo at 40 °C overnight to give 18 (6.08 g, 
92%). 1H NMR (CDCl3): δ 8.09 (dd, 1H, J = 0.4, 1.8 Hz), 7.66−7.59 (m, 2H), 7.50-7.47 (m, 1H), 
5.55 (s, 2H), 2.76-2.72 (m, 4H). 
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Diphenylphosphino(borane))methanethiol-2-Nitrobenzylsuccinate ester (19) 
13 (0.4 g, 1.38 mmol) was dissolved in freshly distilled methanol (5 mL), followed by addition 
of NaOH (66 mg, 1,66 mmol). After stirring under nitrogen for 10 min, the solution was 
neutralized by 1 N HCl, and was extracted with EtOAc (2 x 30 mL). The combined organic 
layers were washed by brine (1 x 10 mL), dried over sodium sulfate, filtered, and concentrated 
under reduced pressure. The crude thiol (14) was dissolved in freshly distilled CH2Cl2 (10 mL), 
followed by addition of 18 (0.408 g, 1.58 mmol), DCC (0.4 g, 0.97 mmol), and cat. 
N,N’-dimethyl-4-aminopyridine. The solution was stirred under nitrogen for 4 h, and the solution 
was filtered through a pad of celite. The solvent was removed under reduced pressure. The crude 
product was purified by flash chromatography (3:1 C6H14:EtOAc) to yield the thioester 19 as a 
colorless oil (0.432g, 65%). 1H NMR (CDCl3, 300MHz) δ 8.10 (t, 1H, J = 1.2 Hz), 7.85-7.83 (m, 
1H), 7.82-7.80 (m, 4 H), 7.69-7.43 (m, 8H), 5.61 (s, 2H), 3.73 (d, 2H, J = 1.2 Hz), 2.85 (t, 2H, J 
= 4.2 Hz), 2.67 (t, 2H, J = 4.2 Hz). 13C NMR (CDCl3, 75 MHz) δ 195 (d), 170, 147.4, 133.9, 
132.4, 132.4, 132.0, 131.8, 131.4, 131.3, 129.0, 128.9, 128.9, 128.8, 128.7, 128.6, 127.6, 127.2, 
125.0, 63.3, 37.9, 29.0, 23.6 (d). 31P NMR (CDCl3, 300 MHz) δ 40.4; 
 
Diphenylphosphinomethanethiol-2-Nitrobenzylsuccinate ester (20) 
19 (0.2 g, 0.41 mmol) and DABCO (0.139 g mg, 1.24 mmol) was dissolved in freshly distilled 
toluene (2 mL). The solution was submerged in an oil-bath pre-heated to 60 °C. The solution was 
stirred under argon for 1 h. After cooling to r.t., the solvent was removed under reduced pressure. 
The crude product was purified by flash chromatography (3:1 C6H14:EtOAc) under nitrogen to 
yield 20 as a colorless oil (0.15 g, 80%). 1H NMR (CDCl3) δ 8.10 (dd, 1 H, J = 0.6, 4.8 Hz), 
7.66-7.63 (m, 2H), 7.46-7.42 (m, 5H),  7.36-7.34 (m, 6H),  5.52 (s, 2H), 3.53 (d, 2H, J= 2.1 
Hz), 2.89 (t, 2H, J = 4.2 Hz), 2.73 (t, 2H, J = 4.2 Hz). 13C NMR (CDCl3, 75 MHz) δ 196 (d), 171. 
2, 147.4, 136.7, 136.6, 133.8, 132.8, 132.6, 131.9, 129.2, 128.9, 128.8, 128.7, 128.6, 128.5, 120.0, 
63.2, 38.1, 29.1, 25.7 (d). 31P NMR (CDCl3, 300 MHz) δ - 15.1. 
 
2. The identification of AznLRS 
2.1 Construction of the mmPylRS Library and the selection of pEvol-PylT-AznLRS  
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AznL was genetically encoded into sfGFP in E. coli BL21(DE3) cells using a mutant 
pyrrolysyl-tRNA synthetase (PylRS)-tRNACUA pair. An active-site mutant library of the 
Methanosarcina mazei PylRS gene that randomizes at active site residues (Y306NNK, 
L309NNK, C348NNK, Y/F/W384 and W411NNN). NNK (N=A or C or G or T, K=G or T) was 
constructed by site-directed mutagenesis PCR. The following pairs of primers were used to 
generate the mmPylRS gene library, pBK-mmPylRS-348NNK-F: 5’-ACC ATG CTG AAC TTC 
NNK CAG ATG GGA TCG GGA TGC ACA CGG-3’, pBK-mmPylRS-348NNK-R: 5’-AAA 
CTC TTC GAG GTG TTC TTT GCC GTC GGA CTC-3’, pBK-mmPylRS-306-309-NNK-F: 
5’-CTT GCT CCA AAC CTT NNK AAC TAC NNK CGC AAG CTT GAC AGG GCC CTG 
CCT-3’, pBK-mmPylRS-306-309-NNK-R: 5’-CAT GGG TCT CAG GCA GAA GTT CTT 
GTC AAC CCT-3’; pBK-mmPylRS-411NNN-F: 5’-CCG CTT GAC CGG GAA NNN GGT 
ATT GAT AAA CCC-3’, and pBK-mmPylRS-411NNN-R: 5’-TAT GGG TCC GAC TAC TGC 
AGA GG-3’. The DNA library was cloned into a pBK vector to form a pRSL library.  
 
Positive selection: The pRSL plasmid library was used to transform TOP10 electrocompetent 
cells containing the positive selection plasmid pY+ to yield a cell library greater than 1×109 cfu, 
ensuring complete coverage of the pRSL library. Cells were plated on minimal agar plates 
containing 12 µg/mL tetracycline (Tet), 25 µg/mL kanamycin (Kan), 102 µg/mL 
chloramphenicol (Cm) and 1 mM AznL. After incubation at 37 °C for 72 h, colonies on the 
plates were collected and surviving pRSL plasmids were extracted.  
 
Negative selection: the extracted plasmids from the positive selection were transformed into 
TOP10 electrocompetent cells containing the negative selection plasmid pY- and plated on LB 
agar plates containing 50 µg/mL Kan, 200 µg/mL ampicillin (Amp), 0.2% arabinose. After 
incubation at 37 °C for 16 h. Survived cells from plates were pooled to extract plasmids for 
further selections.  
 
The alternative positive (3×) and negative (2×) selections were repeated. Final positive selected 
colonies grew on LB plates with 102 µg/mL Cm, 25 µg/mL Kan, 12 µg/mL Tet, and with or 
without 1 mM AznL. 
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2.2 The sequencing results of the selected AznLRS 
The sequences of the six selected colonies are listed in SI Table 1. 
 
SI Table 1. The mutants for Aznl incorporation and the sequence 
RS mutants Sequences 
AznLRS1 306L309L348I384F411W 
AznLRS3 306F309M348M384F411W 
AznLRS4 306L309L348V384F411F 
AznLRS9 306L309L348L384F411W 
AznLRS20 & 45 306L309L348I384F411W 
 
The AznLRS1 was sequenced optimized and cloned into a pEVOL vector that has a gene coding 
tRNAPyl to afford the plasmid pEVOL-pylT-AznLRS.  
 
3. The expression of sfGFP-D134AznL and wild type sfGFP 
3.1 DNA sequences of sfGFP-D134TAG and wild type sfGFP 
sfGFP-D134TAG-His6: 
atggttagcaaaggtgaagaactgtttaccggcgttgtgccgattctggtggaactggatggtgatgtgaatggccataaatttagcgttcgtggcgaaggcgaaggtgat
gcgaccaacggtaaactgaccctgaaatttatttgcaccaccggtaaactgccggttccgtggccgaccctggtgaccaccctgacctatggcgttcagtgctttagccgc
tatccggatcatatgaaacgccatgatttctttaaaagcgcgatgccggaaggctatgtgcaggaacgtaccattagcttcaaagatgatggcacctataaaacccgtgcg
gaagttaaatttgaaggcgataccctggtgaaccgcattgaactgaaaggtattgattttaaagaatagggcaacattctgggtcataaactggaatataatttcaacagcca
taatgtgtatattaccgccgataaacagaaaaatggcatcaaagcgaactttaaaatccgtcacaacgtggaagatggtagcgtgcagctggcggatcattatcagcagaa
taccccgattggtgatggcccggtgctgctgccggataatcattatctgagcacccagagcgttctgagcaaagatccgaatgaaaaacgtgatcatatggtgctgctgga
atttgttaccgccgcgggcattacccacggtatggatgaactgtataaaggcagccaccatcatcatcaccattga 
 
3.2 Protein sequences of sfGFP-D134TAG 
sfGFP-D134AznL-His6 (MW: 27866.35): 
(M)VSKGEELFTGVVPILVELDGDVNGHKFSVRGEGEGDATNGKLTLKFICTTGKLPVPWPTLVTTLTYGVQ
CFSRYPDHMKRHDFFKSAMPEGYVQERTISFKDDGTYKTRAEVKFEGDTLVNRIELKGIDFKE(Aznl)GNIL
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GHKLEYNFNSHNVYITADKQKNGIKANFKIRHNVEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSVLS
KDPNEKRDHMVLLEFVTAAGITHGMDELYKGSHHHHHH 
 
3.3 The expression and purification of sfGFP-D134AznL  
The plasmid of pEvol-PylT-AznLRS mentioned before was used together with 
pET-sfGFP-D134TAG to co-transform E.coli BL21(DE3) cells. The cells were plated on LB 
agar plate containing 100 µg/mL ampicillin (Amp) and 34 µg/mL chloramphenicol (Cam). A 
single colony was picked, followed by the growth in a 5 mL LB medium overnight. The 
overnight culture was further inoculated into a 250 mL 2YT medium with the same 
concentration of Amp and Cam. Cells were let grow in a 37 oC shaker (250 r.p.m.) for 3 h until 
OD600 reached 0.6. The protein expression was induced by the addition of 1 mM IPTG, 0.2% 
arabinose and 5 mM AznL as the final concentration. After another 8 h incubation, the cells were 
harvested (4k 20 min, 4 oC), washed, and fully resuspended with a lysis buffer (300 mM NaCl, 
50 mM NaH2PO4, 10 mM imidazole, pH 7.5). The sonication of cells underwent under ice/water 
incubation for 3 times (4 min each time with an interval of 4 min). Then the cell lysate was 
centrifuged (10k 40 min, 4 oC), and the precipitate was removed. 1 mL Ni SepharoseTM 6 Fast Flow 
column (GE Healthcare) was added to the supernatant and incubated for 1 h at 4 oC. The mixture 
was loaded to a column and the flow-through was removed. 15 mL of wash buffer (300 mM 
NaCl, 50 mM NaH2PO4, 20 mM imidazole, pH 7.5) was used to wash the protein-bound resin in 
three batches. Around 6 mL of elution buffer (300 mM NaCl, 50 mM NaH2PO4, 250 mM 
imidazole, pH 7.5) was used to elute the target protein. All the eluted fractions were collected 
and concentrated by Amicon Ultra-15 Centrifugal Filter Device (10k MWCO, Millipore), and 
buffer was exchanged to 20 mM phosphate pH 8.5 buffer. FPLC Q-Sepharose anion exchange 
column was used to further purify the sfGFP. Buffer A is 20 mM phosphate pH 8.5 buffer, while 
buffer B 20 mM phosphate pH 8.5 buffer containing 1 M NaCl. The wash with 10 column 
volume (CV) of mobile phase containing 5 % B was followed by the elution of a gradient from 
5 % to 50 % B in 10 CV mobile phase. The elution samples were collected and again 
concentrated by Amicon Ultra-15 Centrifugal Filter Device (10k MWCO, Millipore). The buffer 
was further exchanged to 200 mM phosphate pH 6.5 buffer for the further Staudinger reaction. 
The expression of wild type sfGFP followed the similar procedure without the addition of AznL 
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for induction. 
 
3.4 Fluorescent labeling of sfGFP-D134AznL 
The fluorescent labeling of sfGFP-D134AznL was carried out according to standard CuAAC 
procedure2. 50 µM of CuSO4 was mixed with 300 µM of BTTAA, followed by the addition of 
500 µM alkyne-fluorescein, and 15 µM of sfGFP-D134AznL (all the mentioned were final 
concentrations). The reaction was initialized by the addition of ascorbate stock solution in PBS 
to a final concentration of 2.5 mM. The same reaction was carried out for wild type sfGFP. The 
reaction was allowed to be incubated at 25 oC for 4 h followed by the SDS-PAGE gel analysis.  
 
SI Fig. 1: A. fluorescent labeling of sfGFP-D134AznL. B. the structure of alkyne-fluorescein. 
 
4. The expression of Ub-K48AznL, WT-Ub, and Ub-K48ac 
4.1 DNA sequences of Ub-K48TAG-His6 
Ub-K48TAG-His6  
atgcaaatattcgtgaaaaccctaactggtaagaccatcactctcgaagtggagccgagtgacaccattgagaatgtcaaggcaaagatcca
agacaaggaaggcatccctcctgaccagcagaggttgatctttgctgggtagcagctggaagatggacgcaccctgtctgactacaacatc
cagaaagagtccaccctgcacttggtccttaggctgagaggaggacatcaccatcaccatcactaa 
 																																																								2	 C.	Besanceney-Webler,	H.	Jiang,	T.	Zheng,	L.	Feng,D.	Soriano	del	Amo,	W.	Wang,	L.	M.	Klivansky,	Prof.	Dr.	F.	L.	Marlow,	Dr.	Y.	Liu,	Prof.	Dr.	P.	Wu,	Angew.	Chem.	Int.	Ed.	2011,	50,	8051	–8056	
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4.2 Protein sequences of Ub-K48AznL and Ub-K48ac  
Ub-K48AznL-His6 
MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAG(Aznl)QLEDGRTLSD
YNIQKESTLHLVLRLRGGHHHHHH 
 
Ub-K48ac-His6 
MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAG(AcK)QLEDGRTLSD
YNIQKESTLHLVLRLRGGHHHHHH 
 
4.3 The expression and purification of Ub-K48AznL, Ub-K48ac 
All antibodies were purchased from PTM BioLabs Inc.  
The plasmid of pEvol-PylT-AznLRS mentioned before was co-transferred with 
pET-Ub-K48TAG into E.coli BL21(DE3) cells. The cells were plated on LB agar plate 
containing 100 µg/mL ampicillin (Amp) and 34 µg/mL chloramphenicol (Cam). A single colony 
was picked, followed by the growth in a 5 mL LB medium overnight culture. The overnight 
culture was further inoculated 250 mL of 2YT medium with the same concentration of Amp and 
Cam. Cells grew in a 37 oC shaker (250 r.p.m.) for 3 hrs until OD600 reached 0.6. The protein 
expression was induced by the addition of 1 mM IPTG, 0.2% arabinose and 5 mM Aznl as the 
final concentration. After another 8 h incubation, the cells were harvested (4k 20 min, 4 oC), 
washed, and fully resuspended with PBS. The sonication of cells underwent under ice/water 
incubation for 3 times (4 min each time with a interval of 4 min). Then the cell lysate was 
centrifuged (10k 40 min, 4 oC), and the precipitate was removed. The supernatant was adjusted 
pH to 3.5 with acetic acid, and was incubated for 20 min before centrifuging (10k 40 min, 4 oC). 
After the removal of precipitation, 1 mL Ni SepharoseTM 6 Fast Flow column (GE Healthcare) was 
added to the supernatant and incubated for 1 h at 4 oC. The mixture was loaded to a column and 
the flow-through was removed. 50 mL of wash buffer (300 mM NaCl, 50 mM NaH2PO4, 20 mM 
imidazole, pH 7.5) was used to wash the protein-bound resin in three batches. Around 6 mL of 
elution buffer (300 mM NaCl, 50 mM NaH2PO4, 250 mM imidazole, pH 7.5) was used to elute 
the target protein. All the eluted fractions were collected and concentrated by Amicon Ultra-15 
Centrifugal Filter Device (3.5k MWCO, Millipore), and buffer was exchanged to 200 mM 
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phosphate pH 6.5 buffer for the further traceless Staudinger ligation. For the expression of 
Ub-K48ac, the pEvol-PylT-AcKRS was used instead, while 5 mM of AcK was provided while 
induction. All the other purification steps remain the same as Ub-K48AznL. 
 
4.4 The expression and purification of wild type Ub 
Wild type Ub with a N-terminal 6×his tag was expressed in a 1 L 2YT culture with the addition 
of 100 µg/mL Amp. Cells were let to grow in a 37 oC shaker (250 r.p.m.) for 3 h until OD600 
reached 0.6. The protein expression was induced by the addition of 0.8 mM IPTG as the final 
concentration. After another 8 h incubation, cells were harvested. The further purification 
processes were the same as the purification of Ub-K48AznL. 
 
5. The expression of histone H3-K4Aznl, WT-H3, and H4-His6-SUMO 
5.1 DNA sequences of WT-H3 
WT-H3(C110A): 
gctcgcaccaaacagactgctcgtaagtccactggcggtaaagcgccgcgtaaacagctggcaaccaagatggcgcgtaaaagcgctccagctactggcggcgtgaa
gaagccgcaccgttatcgcccgggtactgtggctctgcgtgaaatccgccgctaccagaaaagcaccgaactgctgattcgcaaactgccatttcaacgtctggttcgcg
aaattgctcaggatttcaaaaccgacctgcgcttccagtctagcgctgtgatggcactgcaagaggcgtctgaggcatatctggttggcctgttcgaagataccaacctgtg
cgcaatccatgcaaagcgtgtaaccattatgccgaaagacatccaactggctcgtcgtatccgtggtgagcgtgcgtga 
 
5.2 Protein sequences of His6-TEV-H3-K4AznL(C110A) 
His6-TEV-H3-K4AznL(C110A): 
MGSSHHHHHHSQDPENLYFQART(AznL)QTARKSTGGKAPRKQLATKAARKSAPATGGVKKPHRYRPGT
VALREIRRYQKSTELLIRKLPFQRLVREIAQDFKTDLRFQSSAVMALQEASEAYLVGLFEDTNLAAIHAKRV
TIMPKDIQLARRIRGERA 
 
5.3 The expression and purification of H3-K4AznL 
The plasmid of pEvol-PylT-AznLRS mentioned before was used together with 
pETduet-H3K4TAG to co-transform E.coli BL21(DE3) cells. The cells were plated on LB agar 
plate containing 100 µg/mL ampicillin (Amp) and 34 µg/mL chloramphenicol (Cam). A single 
colony was picked, followed by the growth in a 5 mL LB medium with same Amp Cam 
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concentrations overnight culture. The overnight culture was further inoculated into a 250 mL 
2YT medium with the same concentration of Amp and Cam. Cells were grown in a 37 oC shaker 
(250 r.p.m.) for 3 hrs until OD600 reached 0.6. The protein expression was induced by the 
addition of 1 mM IPTG, 0.2 % arabinose and 5 mM AznL. After another 8 h incubation, the cells 
were harvested by centrifugation (4k 20 min, 4 oC), washed, and fully resuspended in a 40 mL 
lysis buffer (20 mM Tris-HCl, 500 mM NaCl, 0.1% Triton X-100, 0.1% NaN3, pH 7.5). The 
sonication of cells underwent under ice/water incubation for 3 times (4 min each time with an 
interval of 4 min). Then the cell lysate was centrifuged (6k 20 min, 4 oC), and the supernatant 
was removed. The precipitate was washed with 30 mL lysis wash buffer (20 mM Tris-HCl, 500 
mM NaCl, 0.1% NaN3, pH 7.5) twice. The supernatant was removed again, and the inclusion 
body was dissolved in 6 M urea histone solublization buffer (6 M urea, 20 mM Tris, 500 mM 
NaCl, pH 7.5). The solution was centrifuged at 10 k for 40 min to remove all the precipitate. The 
supernatant was loaded to 1 mL Ni SepharoseTM 6 Fast Flow column (GE Healthcare) and the 
flow-through was removed. 15 mL of wash buffer (6 M urea, 20 mM Tris, 500 mM NaCl, 20 
mM imidazole, pH 7.5) was used to wash the protein-bound resin in three batches. Around 6 mL 
elution buffer (6 M urea, 20 mM Tris, 500 mM NaCl, pH 7.5) was used to elute the target 
protein. 
All the eluted fractions were then collected and concentrated by Amicon Ultra-15 Centrifugal 
Filter Device (3 k MWCO, Millipore), and buffer was exchanged to histone solublization buffer 
for the further traceless Staudinger ligation reaction. 
 
5.4 The expression and purification of wild type H3 and H4 
Both histone proteins with a N-terminal 6×his tag were expressed in a 1 L 2YT culture with the 
addition of 100 µg/mL Amp. Cells were let to grow in a 37 oC shaker (250 r.p.m.) for 3 h until 
OD600 reached 0.6. The protein expression was induced by the addition of 0.8 mM IPTG. After 
another 8 h incubation, cells were harvested. The further purification processes were the same as 
the purification of H3-K4AznL. 
 
6. General process of time-dependent traceless-Staudinger ligation of Ub-K48AznL and 
H3K4AznL  
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~5 mg of dPPMT-Ac, dPPMT-Su, and dPPMT-NB-Su were dissolved in DMSO solution to 
reach 100 mM. The Ub-K48AznL, wild type Ub, and Ub-K48ac were all prepared in 200 mM 
phosphate buffer, pH 6.0 with 10-20 µM concentrations. The phosphine reagents in DMSO stock 
solution were slowly added into the Ub-K48AznL (~20 µM) sample to reach to a final 
concentration of 5 mM. Reactions were gently pipetted to make solutions well mixed and then let 
stand at 37 oC. A same amount of wild type Ub with the addition of same amount of phosphine 
reagent was used as the negative control. For the acetylation modification, Ub-K48ac without 
phosphine was used as the positive control. Samples of reaction mixtures were taken 12 h 
intervals. 5 µL of azidoethanol was added to each sample as the quencher, followed by the 
addition of 10× PBS buffer. The quenched samples were centrifuged at 14K for 5 min to remove 
any precipitations, dialyzed over 10× PBS buffer for 3 times, and then concentrated to small 
volumes. For dPPMT-NB-Su, the quenched samples were treated with UV light at 365 nm for 30 
min. With the addition of a SDS loading buffer, final samples were applied to two 15 % 
SDS-PAGE gel separately. The first gel was stained with Coomassie blue and applied for 
imaging. The second gel was further transferred to nitrocellulose membrane for Western blot. 
The pan anti-Kac or pan anti-Ksu antibody from PTM BioLabs Inc. was first applied and then 
followed by the blotting with secondary antibody and visualization. For H3K4su, the degassed 
histone solublization buffer at pH 6.0 instead of a PBS buffer was used when it was necessary. 
 
7. MS analysis of sfGFP-D134AznL, Ub-K48ac, and Ub-K48su 
The purified sfGFP-D134AznL was dialyzed against 20 mM ammonium bicarbonate (ABC) 
buffer, followed by the complete removal of solvent with lyophilization. The solid protein 
powder was then dissolved in 40 % ACN/water with 0.1 % formic acid, and injected to ESI-MS 
(Applied Biosystems QSTAR Pulsar, Concord, ON, Canada, equipped with a nanoelectrospray 
ion source). The deconvoluted data was analyzed by Protein Deconvolution Software from the 
same company. The products Ub-K48ac and Ub-K48su from traceless-Staudinger ligation were 
directly applied to Ziptip (Reversed-phase, pipette tips for sample preparation, Millipore 
Corporation) sample preparation, followed by the analysis of MALDI-TOF-MS (Applied 
Biosystems Voyager-DE STR) with data explorer software from the same company. 
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8. Tandem MS/MS analysis of Ub-K48ac, Ub-K48su, and H3-K4su 
Liquid Chromatography—tandem Mass Spectrometry (LC-MS/MS) was applied to identify the 
specific modifications to Ub-K48 and histone H3-K4 proteins. The protein digestion, 
LC-MS/MS analysis, and data analysis were conducted following the method described 
previously3. 10 µg of each protein was used for the analysis. Briefly, protein sample was 
denatured by 8 M urea dissolved in Tris buffer (50 mM Tris-HCl, 10mM CaCl2, pH 7.6), 
supplemented with 5 mM dithiothreitol (DTT) for reduction of potential disulphide bonds. The 
denatured protein was diluted into a final concentration of 1 M urea with the same Tris buffer, 
followed by peptide digestion. Ubiquitin was digested by Mass Spectrometry Grade Trypsin 
Gold (Promega, Madison, WI) with 1:50 w/w at 37 °C overnight, while histone H3 was digested 
by chymotrypsin (Promega, Madison, WI) at 25 °C. The digested peptides were then cleaned up 
using a Sep-Pak Plus C18 column (Waters Corporation, Milford, MA), followed by loading onto 
a biphasic 2D reversed phase (RP)/strong cation exchange (SCX) capillary column with a 
pressure cell. The column was then washed with 100% aqueous solvent (99.9 % H2O, 0.1 % 
formic acid) for 5 min, followed by a 1-hour wash by ramping up the solvent to 100% organic 
solvent (0.1 % formic acid, 80% acetonitrile). This washing step migrates all the peptides into 
the SCX phase, where peptides were eluted and separated in a 15-cm-long 100 µm-ID C18 
capillary column connected to the 2D column. LTQ ion trap mass spectrometer (Thermo 
Finnegan, San Jose, CA) was used to analyze the peptides. The full scan was set to the range of 
300-1700 m/z, in which the top 5 abundant peptides in each scan were subjected to collision 
induced dissociation (CID) fragmentation for tandem mass spectrometry (MS/MS) analysis. 
Peptide identity was processed by the in-house pipeline as described previously. Peptide 
searching was based on ProLuCID (version 1.0) search algorism. For the peptide modification 
search, mass increase was added in order to identify the modified peptides. More specifically, 
42.0367 was added for lysine acetylation modification, and 100.0648 was added for lysine 
succinylation modification.   
 
9. The preparation of H3-K4su 																																																								3	 Z.	Wang,	Y.	Zeng,	Y.	Kurra,	X.	Wang,	 J.	M.	Tharp,	E.	C.	Vatansever,	W.	W.	Hsu,	S.	Y.	Dai,	X.	Fang,	W.	R.	Liu,	
Angew.	Chem.	Int.	Ed.	2016,	accepted	
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The preparation of H3-K4su was carried out in large batch with the procedure similar to part 6. 
In each reaction, about 1.5 mg H3-K4AznL was applied to the traceless Staudinger reaction with 
dPPMT-NB-Su, followed by the same reaction work-up process. After concentrating to lower 
volume, the sample was then treated with UV photolysis for 30 min, followed by another dialysis 
against histone solubilization buffer, pH 7.5 for 3 times. The solution was concentrate again 
down to 100 µl and stored for the next step. 
 
10. Refolding of H3K4su-H4 tetramer 
The H3-K4su was assembled into tetramer with wild type H4. Both histone proteins with a 
N-terminal 6×His tag (H4 with SUMO) were dissolved with equimolar ratios in the histone 
solubilization buffer (6 M urea, 20 mM Tris, 500 mM NaCl, pH 7.5). The protein mixture was 
dialyzed against 500 mL refolding buffer 1 (20 mM Tris, 2 M NaCl, pH 7.5) for 30 min once, 
500 mL refolding buffer 2 (20 mM Tris, 1 M NaCl, pH 7.5) for 30 min once, and 500 mL 
refolding buffer 3 (20 mM Tris, 500 mM NaCl, pH 7.5) for 30 min twice by using Slide-A-Lyzer 
MINI Dialysis devices (3,500-Da cutoff). After the refolding process, tetramers were put into a 
microcentrifuge tube and spun down by 14000 rpm for 1 min to remove all the precipitation 
during the refolding process, and the tetramer concentration was about 16 mg/mL. SDS-PAGE 
gel was used to confirm the tetramer folding, and the tetramer was stored on ice for further 
usage. 
 
11. Sirtuin enzyme expression and deacylation assay 
11.1 Sirtuin 1 and Sirtuin 5 expression  
The Sirt1 and Sirt5 were expressed according to the procedure reported4. Both enzymes were 
expressed in E.coli BL21(DE3) cells with 1 L LB media at 30 oC overnight, after the addition of 
IPTG 0.1 mM as an inducer. After collecting cells and their sonication, the precipitate was 
removed by centrifugation. The supernatant was subjected to purification with the GST resin. 
The mixture was directly loaded to a column and the flow-through was removed. 50 mL PBS 
washing buffer (100 mM NaCl, 200 mM NaH2PO4, pH 7.4) was used to wash the protein-bound 
resin in three batches. 10 mL of elution buffer (15 mM Glutathione in reduced form, 100 mM 																																																								4	 Du J., Jiang H., Lin H., Biochemistry 2009, 48, 2878-2890	
23		
NaCl, 200 mM NaH2PO4, pH 7.4) was used to elute the target protein. After concentration 
measurement, the enzymes were split into several portions with glycerol added. The final 
solution was frozen by ethanol-dry ice mixture and stored into -80 oC freezer for future usage.  
 
11.2 Sirtuin enzyme deacylation assay on H3K4su-H4 tetramer 
The H3K4su-H4 tetramer was freshly assembled according to Part 10 at concentration of about 
16 mg/mL or 180 µM. Sirtuin enzyme stock solution was added to each sample as the final 
concentration of 500 nM for Sirt1 or Sirt5. After 4 h incubation at 37 oC, the samples were 
subjected to the SDS-PAGE analysis. SDS-PAGE separated proteins were transferred to 
nitrocellulose membranes for Western blot. The pan anti-Ksu antibody was used for the 
membrane blotting, followed by the Stripping-off5 of the antibody for probing with a generally 
used anti-H3 antibody (Abcam).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix: 																																																								5	 http://www.abcam.com/ps/pdf/protocols/stripping%20for%20reprobing.pdf	
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1HNMR Spectrum of dPPMT-Su 
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13CNMR Spectrum of dPPMT-Su 
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1HNMR Spectrum of dPPMT-NB-Su 
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13CNMR Spectrum of dPPMT-NB-Su 
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